
We are proud to announce our new partnership with Royal Life Saving Society UK (RLSS UK).
Read more
A recent study led by researchers at the Icahn School of Medicine at Mount Sinai, New York, has provided encouraging evidence that a supervised, gradual peanut ingestion protocol may help children with a high-threshold peanut allergy increase their tolerance to
Read more
Anaphylaxis UK is delighted to be working with NHS Trusts in Gateshead & Newcastle-upon-Tyne on their BeatAnaphylaxis course for schools in the North East.
Read more
The University of Manchester is inviting individuals to participate in an event where they can share their healthcare experiences and contribute to meaningful discussions with student researchers. This research opportunity aims to help students learn directly from patients about their
Read more
The National Institute for Health and Care Excellence (NICE) has released its final draft guidance, recommending Acarizax for NHS use in the management of house dust mite allergy. Developed by ALK-Abello, Acarizax is the first therapy specifically designed to treat
Read more
ARS Pharmaceuticals has made significant progress in expanding access to neffy®, its needle-free adrenaline (epinephrine) nasal spray. After gaining approval in the U.S. and Europe for treating severe allergic reactions like anaphylaxis, ARS Pharmaceuticals has now filed for approval in
Read more
A recent announcement from DBV Technologies revealed promising long-term results from its EPITOPE Study. Results from a 3-year study showed that the VIASKIN® Peanut patch can help children with peanut allergies become less sensitive to peanuts, reducing the risk of
Read more
A group of health care professionals and patient representatives have created a Task Force on Food Allergen Ingestion Risk (‘FAIR’) within the European Academy of Allergy and Clinical Immunology (EAACI). This team is working to explore the challenges and needs
Read more
As we look ahead and finalise our plans for 2025, we wanted to take a moment to reflect on some of our highlights from the year that was 2024. From new resources and awareness campaigns to new initiatives and development of our AllergyWise® training programme, we were proud to be able to recognise our 30th anniversary with so many positive strides towards creating a brighter future for those living with serious allergies.
Read more